Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
Dr Joseph Bocchini, president of the National Foundation for Infectious Diseases, discusses influenza vaccination, the 2018-2019 season, common misconceptions about the vaccine, and more.
Sarah Gilbert from the University of Oxford answers our questions about her research on an influenza vaccine that targets cellular immunity for adults aged 65 years and older.
Dimitri Diavatopoulos, PhD, from the Radboud Center for Infectious Diseases in the Netherlands, answers our questions about controlling pertussis incidence worldwide.
Sammy Saab, MD, MPH, from the Ronald Reagan UCLA Medical Center explains the potentially deadly consequences of hepatitis B reactivation in patients being treated for hepatitis C, and why screening for...
Do comorbidities and polypharmacy lead to virologic failure in all populations living with HIV? This was the focus of recent research presented at IDWeek 2018.
In part 5 of 5 of this series on salmonella infection, Dr Ian Plumb, from the CDC, talks about the knowledge gaps that exist and what needs to be done to bridge them.
An 82-year-old man presented with a 1-week history of purple discolored urine in his collection bag. The color of the urine changed after being removed from the bag and being placed in a specimen cup. What...
